Sam Brusco, Associate Editor02.22.22
Safe Orthopaedics has begun a development agreement with Brainlab to make Safe’s instruments navigable.
Brainlab’s spinal navigation helps precisely position pedicle screws and reduce X-ray exposure. Instrument incisions and trajectories can be more precisely planned, and the technology assists with implant positioning in anatomically critical areas for minimally invasive surgery.
The two companies plan to make Safe’s off-the-shelf technologies compatible with Brainlab’s 3D spine and trauma navigation tech. Navigated surgery requires instrumentation that doesn’t tolerate mechanical play that would impair surgical precision.
"Safe's strategy of collaboration with leading players such as Brainlab will enable us to leverage the impact of our technology and consolidate our position as the leader in ready-to-use devices,” Safe Orthopaedics co-founder and technical director Thomas Droulout told the press. “The compatibility of SteriSpinePS 2nd generation, initiated more than a year ago, with Brainlab navigation will allow us to secure the mini-invasive act and a quick recovery of the patient. This new surgical technique is now used by several hundred hospitals worldwide, mainly in Europe and the United States, confirming the trend towards conversion of the global market. In addition to recently announced products such as Hickory and Sycamore, which will have a lasting impact on Safe Orthopaedics' growth, we are preparing for future growth drivers with this partnership.
Brainlab’s spinal navigation helps precisely position pedicle screws and reduce X-ray exposure. Instrument incisions and trajectories can be more precisely planned, and the technology assists with implant positioning in anatomically critical areas for minimally invasive surgery.
The two companies plan to make Safe’s off-the-shelf technologies compatible with Brainlab’s 3D spine and trauma navigation tech. Navigated surgery requires instrumentation that doesn’t tolerate mechanical play that would impair surgical precision.
"Safe's strategy of collaboration with leading players such as Brainlab will enable us to leverage the impact of our technology and consolidate our position as the leader in ready-to-use devices,” Safe Orthopaedics co-founder and technical director Thomas Droulout told the press. “The compatibility of SteriSpinePS 2nd generation, initiated more than a year ago, with Brainlab navigation will allow us to secure the mini-invasive act and a quick recovery of the patient. This new surgical technique is now used by several hundred hospitals worldwide, mainly in Europe and the United States, confirming the trend towards conversion of the global market. In addition to recently announced products such as Hickory and Sycamore, which will have a lasting impact on Safe Orthopaedics' growth, we are preparing for future growth drivers with this partnership.